Article
Impact of pre-existing drug resistance on risk of virological failure in South Africa.
The Journal of antimicrobial chemotherapy - 12 May 2021
Li Jonathan Z, Stella Natalia, Choudhary Manish C, Javed Aneela, Rodriguez Katherine, Ribaudo Heather, Moosa Mahomed-Yunus, Brijkumar Jay, Pillay Selvan, Sunpath Henry, Noguera-Julian Marc, Paredes Roger, Johnson Brent, Edwards Alex, Marconi Vincent C, Kuritzkes Daniel R
Abstract excerpt
OBJECTIVES: There is conflicting evidence on the impact of pre-existing HIV drug resistance mutations (DRMs) in patients infected with non-B subtype virus. METHODS: We performed a case-cohort substudy of the AIDS Drug Resistance Surveillance Study, which enrolled South African patients initiating first-line efavirenz/emtricitabine/tenofovir. Pre-ART DRMs were detected by Illumina sequencing of HIV pol and DRMs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
